PACI, SABRINA
 Distribuzione geografica
Continente #
EU - Europa 3.465
NA - Nord America 2.075
AS - Asia 1.025
SA - Sud America 62
OC - Oceania 11
AF - Africa 10
Continente sconosciuto - Info sul continente non disponibili 7
Totale 6.655
Nazione #
US - Stati Uniti d'America 1.987
GB - Regno Unito 1.262
IT - Italia 858
CN - Cina 510
SE - Svezia 424
DE - Germania 279
TR - Turchia 173
FR - Francia 125
SG - Singapore 103
KR - Corea 102
IE - Irlanda 98
UA - Ucraina 98
CA - Canada 81
EU - Europa 80
FI - Finlandia 71
RU - Federazione Russa 69
IN - India 56
NL - Olanda 53
HK - Hong Kong 43
CO - Colombia 37
DK - Danimarca 31
BE - Belgio 27
BR - Brasile 21
GR - Grecia 18
PL - Polonia 15
ID - Indonesia 12
AU - Australia 10
CH - Svizzera 8
UZ - Uzbekistan 8
VN - Vietnam 8
EG - Egitto 7
MX - Messico 6
CZ - Repubblica Ceca 4
ES - Italia 4
IR - Iran 3
IS - Islanda 3
RO - Romania 3
RS - Serbia 3
SM - San Marino 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AT - Austria 2
JP - Giappone 2
NG - Nigeria 2
NO - Norvegia 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CL - Cile 1
EC - Ecuador 1
IL - Israele 1
JO - Giordania 1
LV - Lettonia 1
MD - Moldavia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PT - Portogallo 1
QA - Qatar 1
ZA - Sudafrica 1
Totale 6.730
Città #
Southend 1.184
Chandler 302
Milan 178
Seattle 158
Beijing 154
Princeton 138
Wilmington 101
Ann Arbor 100
Dublin 93
Redmond 87
Mountain View 79
Toronto 74
Nanjing 68
Somerville 68
Jacksonville 66
Ashburn 62
Hanover 59
Singapore 56
Fairfield 51
Des Moines 49
Boardman 45
Sakarya 44
Hong Kong 42
Dearborn 40
Woodbridge 40
Andover 39
Bogotá 37
Bengaluru 35
Serra 35
Houston 32
Rome 29
Frankfurt am Main 25
Jinan 25
Redwood City 25
Phoenix 24
Shenyang 24
Roxbury 22
Tianjin 22
Cambridge 20
Brussels 18
Nanchang 18
Medford 17
Shanghai 17
Athens 15
Hebei 14
Torino 14
Guangzhou 13
Sunnyvale 12
Warsaw 12
Changsha 11
Istanbul 11
Odernheim 11
Bitonto 10
Helsinki 10
Berlin 9
Turin 9
Eitensheim 8
San Diego 8
Settimo Torinese 8
Zhengzhou 8
Corsico 7
Fuzhou 7
Jiaxing 7
Padova 7
Prato 7
Trieste 7
Varese 7
Chatsworth 6
Florence 6
Hangzhou 6
New York 6
Verona 6
Al `Amiriyah 5
Falls Church 5
Hamburg 5
Naples 5
Ottawa 5
Palermo 5
Belo Horizonte 4
Bergamo 4
Castiglione del Lago 4
Dong Ket 4
Ferrara 4
Geisenheim 4
Genoa 4
Grafing 4
Jakarta 4
Messina 4
Mumbai 4
Napoli 4
Taizhou 4
Belgrade 3
Capriolo 3
Catania 3
Chiari 3
Columbus 3
Ercolano 3
Fremont 3
Genova 3
Kiez 3
Totale 4.173
Nome #
Gammapatia monoclonale in glicogenosi Ib (GSD Ib): case report 239
Cataract and optic disk drusen in a patient with glycogenosis and di George syndrome: Clinical and molecular report 201
Breastfeeding in phenylketonuric (PKU) and hyperphenylalaninemic (HPA) infants : how and why 191
Sostituti proteici a base di aminoacidi vs glicomacropeptide: accettabilità e palatabilità in pazienti fenilchetonurici 185
Could neurological symptomatology precede an acute metabolic crisis in patient affected by propionic aciduria (PA)? A particular case report 160
Assetto lipidico nei pazienti con glicogenosi: l'esperienza della Clinica Pediatrica dell'Ospedale San Paolo 156
Diagnosi differenziale delle linfoadenopatie 149
Quando la chetonuria nel lattante è spia di malattia metabolica 141
Exploring drivers of liking of low-phenylalanine products in subjects with phenyilketonuria using check-all-that-apply method 140
Breastfeeding in phenylketonuric and hyperphenylalaninemic infants : how and why 139
Treating Phenylketonuria : a single centre experience 133
Absence of severe recurrent infections in GSD IB 132
Densità minerale ossea (BMD) nei pazienti affetti da iperfenilalaninemia (HPA): ruolo della supplementazione con calcio e dell'attività fisica 128
Lens opacities in glycogenoses type i and III 125
Mineralizzazione ossea in pazienti con GSD 1. e 3. 124
Bone mineralization in type 1 glycogen storage disease: a two years follow up study 124
Use of fibroscan in monitoring liver impairment in glycogen storage disease type I and III 123
Disease natural history in a large group of genetically diagnosed glycogen storage disease type III. 120
Amino acid status 6 hours after the assumption of two amino acid preparations in PKU patients on diet-therapy 118
Docosahexaenoic acid through childhood: functional role, metabolic association and therapeutic effects 116
A case of glycogenosis type IB associated with MGUS 116
Bone mineralization in GSD I and III 115
Bone metabolism and hypovitaminosis D in patients affected by glycogen storage disease type I (GSD I) 115
Case report: GSD type 1. and pregnancy 113
Phenylketonuria : nutritional advances and challenges 113
Cardiovascular risk factors in hyperphenylalaninemic children on dietary treatment : correlation between carotid intima-media thickness and docosaexahenoic acid supplementation 112
Acidi grassi polinsaturi a lunga catena (LCPUFA) 110
Bone mineral density (BMD) in patients affected by hyperphenylalanynemia (HPA) : effects of calcium integration and physical activity evaluated with dual energy x-ray absorptiometry (DEXA) 109
Psychosocial distress in PKU female patients with good and bad metabolic control 107
Thyroid and glycogenosis 107
Un caso caratterizzato da macchie caffè-latte 107
Glicogenosi tipo 1. : dieta e salute dell’osso 106
Il trattamento con vitamina E migliora la neutropenia e riduce la frequenza di infezioni nei pazienti con glicogenosi tipo 1b 106
Psychosocial distress in PKU female patients with good and bad metabolic control 105
Hyperphenylalaninemia and potential renal acid load (PRAL) 105
Heart disease and inborn errors of metabolism: prevalence, manifestations and correlation with the specific ongoing treatment in 42 patients followed at San Paolo Hospital, Milan 104
Diagnosticare la malattia di Fabry per curarla 99
Ipertransaminasemia da indagare in lattanti extra-comunitari 98
Is phenylalanine (Phe) loading test still necessary for hyperphenylalaninemia patient with basal plasma level < 360 micromol/l? 98
Bone mass density and body composition measured with dexa in patient affected by hyperphenilalaninemia 96
Determinants of Plasma Docosahexaenoic Acid Levels and Their Relationship to Neurological and Cognitive Functions in PKU Patients: A Double Blind Randomized Supplementation Study 96
Severe PRPS Deficienty in an Adult Lawyer with Normal IQ 95
Malattie metaboliche 94
Evaluation of phenylalanine brain metabolism in three adult patients affected by PKU through magnetic resonance spectroscopy after six months of supplementation with LNAA 93
Nutritional indices and polyunsaturated fatty acids in PKU patients at 20 days of life 91
Le glicogenosi non sono solo malattie dei glucidi 90
Un episodio di febbre elevata in un lattante di quattro mesi con tosse a alvo diarroico 89
Patologia responsabili di ipertransaminasemia 89
Un quadro clinico disturbato da episodi di sopore e vomito 89
Fourty years of nutritional follow-up in PKU patients 87
Un caso complesso di metabolismo del rame alterato 86
Resting energy expenditure in patients affected by glicogen storage disease type I and III 84
Genotype, basal PHE levels and type of nourishment as predictive factors of the BH4 loading test response in phenylketonuria (PKU) affected patients 84
Una patologia d’accumulo associata a crisi ipoglicemiche 83
La pre-eclampsia: implicazioni materne e feto-neonatali 83
PKU in Italy 81
Iperfenilalaninemie : Raccomandazioni diagnostiche, therapeutiche ed assistenziali 80
Maternal PKU and heterozygous women for hyperphenylalaninemia (HPA) : what is the outcome for issue? 77
Efficacy of enzyme replacement therapy over six-months in a non-classic infantile Pompe disease form: our experience in a 2-year-old affected child 75
Maternal PKU and heterozygous women for hyperphenylalaninemia (HPA) : what is the outcome for the offspring? 73
La cataratta congenita 70
Evaluation of bone mass density and body composition measured with DEXA in patient affected by hyperphenylalaninemia 70
Pre-diagnosis weight increase and phenylalanine levels in PKU patients 61
Erythrocyte Galactose-1-phosphate measurement by GC-MS in the monitoring of classical galactosemia 59
Severe PTPS deficiency in an adult lawyer with normal IQ 52
Parents' experience of the communication process of positivity at newborn screening for metabolic diseases: A qualitative study 36
Totale 7.152
Categoria #
all - tutte 16.964
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.964


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201942 0 0 0 0 0 0 0 0 0 0 0 42
2019/2020771 115 33 19 55 37 76 44 73 115 157 28 19
2020/2021799 26 50 106 14 79 54 39 41 95 59 206 30
2021/2022732 76 16 91 16 34 36 78 16 99 49 31 190
2022/2023987 107 109 110 107 121 182 26 54 108 20 31 12
2023/2024503 20 64 41 17 134 14 16 24 8 29 74 62
Totale 7.152